Compare CVS Health Corp (CVS) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs State Street SPDR S&P Homebuilders ETF — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while State Street SPDR S&P Homebuilders ETF trades at $95 (market cap $1.49B). The key difference: CVS Health Corp is far larger — about 75.4× State Street SPDR S&P Homebuilders ETF's market cap, and CVS Health Corp pays a 3.03% dividend while State Street SPDR S&P Homebuilders ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| CVS | XHB | |
|---|---|---|
Market Cap | $112.29B | $1.49B |
Volume | 7,763,676 | 2,445,587 |
Sector | Health | Broad Market / Factor |
52-Week High | $110.60 | $121.36 |
52-Week Low | $70.08 | $94.86 |
Typical Hold Time | 83 Days | 33 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
XHB (SPDR S&P Homebuilders ETF) trades at $94.89, down 2.55% amid broader housing sector pressure from rising mortgage rates. Technical indicators show bearish momentum with moving averages signaling sell pressure, though RSI suggests potential oversold conditions. Recent news highlights institutional interest with Greenland Capital's $17.33 million investment, while new housing legislation and mixed home sales data create uncertainty. The ETF's valuation metrics remain undisclosed in current data.
The housing ETF faces headwinds from 7% mortgage rates but benefits from structural demand and policy support. Near-term performance hinges on interest rate trends and housing market data, with current technical weakness offering potential entry points for long-term housing recovery bets. Key risks include prolonged high rates and economic slowdown impacting buyer affordability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
